KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER

被引：0
|
作者：
Ben Hamida, Karim [1 ]
Houcine, Yoldez [2 ]
Maaoui, Amal [2 ]
Hamza, Khedija [2 ]
Kamoun, Salma [2 ]
Ayadi, Senda [2 ]
Chargui, Riadh [1 ]
Driss, Maha [2 ]
机构：
[1] Salah Azaiez Inst Oncol, Surg Oncol Dept, Tunis, Tunisia
[2] Salah Azaiez Inst Oncol, Pathol Dept, Tunis, Tunisia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷
关键词：
D O I：
10.1136/ijgc-2022-igcs.116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP025/#611
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [31] Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
    Cabrera-Galeana, Paula
    Munoz-Montano, Wendy
    Lara-Medina, Fernando
    Alvarado-Miranda, Alberto
    Perez-Sanchez, Victor
    Villarreal-Garza, Cynthia
    Marisol Quintero, R.
    Porras-Reyes, Fany
    Bargallo-Rocha, Enrique
    Del Carmen, Ignacio
    Mohar, Alejandro
    Arrieta, Oscar
    [J]. ONCOLOGIST, 2018, 23 (06): : 670 - 678
  • [32] Prognostic (Px) significance of Ki67 before and after neoadjuvant chemotherapy (CT) in early breast cancer
    Jones, R. L.
    Salter, J.
    Nerurkar, A.
    Parton, M.
    A'Hern, R.
    Smith, I. E.
    Dowsett, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Relationship between Ki67 and the efficacy of neoadjuvant chemotherapy: clinicopathological characteristics of luminal B breast cancer
    Wang, Jiayu
    Sang, Die
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Luo, Yang
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Fan, Ying
    Chen, Shanshan
    Li, Qiao
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6044 - 6048
  • [34] Evaluation of Ki67 proliferation index before and during neoadjuvant chemotherapy for primary breast cancer.
    Burcombe, RJ
    Makris, A
    Richman, PI
    Daley, F
    Pittam, M
    Wilson, GD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S67 - S67
  • [35] Quantitative Ki-67 score as predictive of response to neoadjuvant chemotherapy in breast cancer
    Brown, Jason R.
    Lannin, Donald R.
    Killelea, Brigid K.
    DiGiovanna, Michael
    Rimm, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer.
    Kolberg-Liedtke, Cornelia
    Hussein, Shady
    Bankfalvi, Agnes
    Steinborn, Julia
    Ting, Saskia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Pott, Birgit
    Hannig, Carla Verena
    Wetzig, Sarah
    Kolberg, Hans-Christian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer—Effects of Age and Tumor Ki67
    Judy C. Boughey
    Tanya L. Hoskin
    Matthew P. Goetz
    [J]. Annals of Surgical Oncology, 2022, 29 : 5757 - 5758
  • [38] Platelet count, platelet lymphocyte ratio, and Ki67 as a predictive factor of neoadjuvant chemotherapy response in locally advanced breast cancer
    Priyono, Sasongko Hadi
    Badriatunnor
    Noor, Meitria Syahadatina
    Wibowo, Agung Ary
    Sanyoto, Didik Dwi
    Ardansyah, Audi
    [J]. BALI MEDICAL JOURNAL, 2023, 12 (02) : 1703 - 1707
  • [39] Ki67 and proliferation in breast cancer
    Pathmanathan, Nirmala
    Balleine, Rosemary L.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 512 - 516
  • [40] Clinical validity and clinical utility of Ki67 in early breast cancer
    Kreipe, Hans
    Harbeck, Nadia
    Christgen, Matthias
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
12345